Only include non-confidential information in this application. In order to assess your application’s commercial and diagnostic merit MRCT reserves the right to share the information you provide with its industrial and pharmaceutical partners.
TITLE: Dr/Ms etc
DIAGNOSTIC TARGET NAME:
TYPE OF DIAGNOSTIC: (single option selectable)
Antibody Small molecule Peptide Conjugate RNA DNA Protein
DISEASE AREA/S: (multi options selectable)
Blood Cardiovascular Congenital disorders Ear Eye Generic health relevance Infection Inflammatory/immune system Injuries/accidents Mental health Metabolic and endrocine Musculoskeletal Neorological Oncology Oral and gastrointestinal Precision medicene Renal and urogenital Reproductive health/childbirth Respiratory Skin Stroke
Please comment on the clinical need of your diagnostic assay. (For example, how the diagnostic assay will improve healthcare).
Maximum 100 words.
What is the biological rationale that detection of the target analyte can lead to an improved clinical outcome? Please include supporting peer reviewed publications, including your own.
Maximum 200 words.
Describe the technology readiness of your diagnostic assay. Include a brief description of the assay, associated technology and reagents. (For example, describe if you have a working assay and how much testing has been carried out to date).
What published literature is there on the diagnostic target or its clinical utility? This may include your published data and other pertinent citations.
Comment on what reagents you currently have available or could be readily produced. (For example, peptides, proteins, antibodies, RNA, DNA, standards or controls).
Maximum 150 words.
Provide details of the level of resources committed to the project to date including the number of staff currently working on the project.
Do you have any IP in the area and is there any competing IP/research? Briefly detail and if appropriate give patent number(s), priority date(s) and status.
What is the current status and next stage of the project? How will a collaboration with MRC Technology support the development of the project?
WHAT WILL THE ASSAY BE USED FOR/AS? (multi options selectable)
Research tool Risk assessment Screening Diagnosis Staging and prognosis Therapy selection Monitoring Companion diagnostic
IN WHICH SETTING/S WILL THE TEST BE PERFORMED? (multi options selectable)
Point of care Primary care End user Central / reference libraries
Only include non-confidential information in this application. In order to assess your application’s commercial and diagnostic merit MRCT reserves the right to share the information you provide with its industrial and pharmaceutical partners. By submitting your application you are explicitly accepting these terms.